Invivyd (NASDAQ: IVVD) revenue
Invivyd reported revenue of $53.4m for fiscal 2025, 110.5% more than in fiscal 2024 ($25.4m).
Fiscal 2025 is the highest of the 3 fiscal years on record for Invivyd.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $53.4m | +110.5% | −$55.6m | −104.0% |
| 2024 | $25.4m | — | −$176.9m | −696.8% |
| 2023 | $0.0m | — | −$212.8m | — |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Invivyd revenue compared with its sector
By revenue for its latest fiscal year, Invivyd ranks 325th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Invivyd, 110.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 323rd | Nektar Therapeutics | $55.2m | −43.9% |
| 324th | Agios Pharmaceuticals | $54.0m | 48.0% |
| 325th | Invivyd | $53.4m | 110.5% |
| 326th | Protalix Biotherapeutics | $52.7m | −1.2% |
| 327th | Ocular Therapeutix | $52.0m | −18.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Invivyd
- How much revenue did Invivyd make in fiscal 2025?
- Invivyd reported revenue of $53.4m for fiscal 2025, compared with $25.4m in fiscal 2024.
- What was the best year for revenue at Invivyd?
- Of its last 3 fiscal years, fiscal 2025, with $53.4m.
- Where does Invivyd rank in its sector by revenue?
- It ranks 325th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Invivyd come from?
- From the annual report (Form 10-K) that Invivyd files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Invivyd files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on Invivyd: the Invivyd page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.